FDA grants clearance for Endogena’s age-related macular degeneration treatment
25th October 2023 Uncategorised 0The company will launch a clinical investigation of EA-2351 for geographic atrophy
More: FDA grants clearance for Endogena’s age-related macular degeneration treatment
Source: News